Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chih-Lin Hsieh

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Cell|December 27, 2008
Germline competent embryonic stem cells derived from rat blastocystsPing Li, Chang Tong, Ruty Mehrian-Shai, et al.
Frontiers in Oncology|December 20, 2021
Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic LeukemiaYongsheng Ruan, Hye Na Kim, Heather A Ogana, et al.
Genetic Epidemiology|June 18, 2016
Post hoc Analysis for Detecting Individual Rare Variant Risk Associations Using Probit Regression Bayesian Variable Selection Methods in Case-Control Sequencing StudiesNicholas B Larson, Shannon McDonnell, Lisa Cannon Albright, et al.
Genetic Epidemiology|February 18, 2017
gsSKAT: Rapid gene set analysis and multiple testing correction for rare-variant association studies using weighted linear kernelsNicholas B Larson, Shannon McDonnell, Lisa Cannon Albright, et al.
European Urology|August 18, 2020
Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate CancerDaniel J Schaid, Shannon K McDonnell, Liesel M FitzGerald, et al.
American Journal of Human Genetics|September 27, 2016
REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense VariantsNilah M Ioannidis, Joseph H Rothstein, Vikas Pejaver, et al.
Human Genetics|December 27, 2011
Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG)Guangfu Jin, Lingyi Lu, Kathleen A Cooney, et al.
The Prostate|March 25, 2010
Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analysesG Bryce Christensen, Agnes B Baffoe-Bonnie, Asha George, et al.
Human Molecular Genetics|May 5, 2007
Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer GeneticsNicola J Camp, Lisa A Cannon-Albright, James M Farnham, et al.
Human Genetics|October 29, 2013
Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial diseaseCraig C Teerlink, Stephen N Thibodeau, Shannon K McDonnell, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Cell|December 27, 2008
Germline competent embryonic stem cells derived from rat blastocystsPing Li, Chang Tong, Ruty Mehrian-Shai, et al.
Frontiers in Oncology|December 20, 2021
Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic LeukemiaYongsheng Ruan, Hye Na Kim, Heather A Ogana, et al.
Genetic Epidemiology|June 18, 2016
Post hoc Analysis for Detecting Individual Rare Variant Risk Associations Using Probit Regression Bayesian Variable Selection Methods in Case-Control Sequencing StudiesNicholas B Larson, Shannon McDonnell, Lisa Cannon Albright, et al.
Genetic Epidemiology|February 18, 2017
gsSKAT: Rapid gene set analysis and multiple testing correction for rare-variant association studies using weighted linear kernelsNicholas B Larson, Shannon McDonnell, Lisa Cannon Albright, et al.
European Urology|August 18, 2020
Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate CancerDaniel J Schaid, Shannon K McDonnell, Liesel M FitzGerald, et al.
American Journal of Human Genetics|September 27, 2016
REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense VariantsNilah M Ioannidis, Joseph H Rothstein, Vikas Pejaver, et al.
Human Genetics|December 27, 2011
Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG)Guangfu Jin, Lingyi Lu, Kathleen A Cooney, et al.
The Prostate|March 25, 2010
Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analysesG Bryce Christensen, Agnes B Baffoe-Bonnie, Asha George, et al.
Human Molecular Genetics|May 5, 2007
Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer GeneticsNicola J Camp, Lisa A Cannon-Albright, James M Farnham, et al.
Human Genetics|October 29, 2013
Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial diseaseCraig C Teerlink, Stephen N Thibodeau, Shannon K McDonnell, et al.
Pageof 8